I will be presenting my research at the Society for Neuroscience (SfN) conference in San Diego this November. My research is centered around developing a protective treatment for Parkinson’s disease in rats that may slow disease progression, and studying how our treatment is creating its effects. Parkinson’s disease is the second most common neurodegenerative disorder with approximately 50,000 new cases being diagnosed in the United States each year. Existing treatments for Parkinson’s patients, while effective to treat symptoms, do not slow the underlying disease progression, eventually rendering additional symptomatic treatment ineffective.
SfN is an international meeting attended by leading experts in neuroscience that I would not otherwise have a chance to meet. Presenting my research at this meeting will provide an invaluable forum for discussion with these individuals. During the first day of the conference I will also attend a course on movement disorders, providing the opportunity to learn from and network with experts in my more focused field of Parkinson’s disease. Networking at SfN this year in particular will be vital. I am in my final year of study and will be building relationships to foster future collaborations and career advancement opportunities as I move forward this year.
Medical University of South Carolina
Founded in 1824, The Medical University of South Carolina (MUSC) continues the tradition of excellence in education, research and patient care. MUSC educates and trains more than 3,000 students and residents in six colleges and has nearly 13,000 employees, including approximately 1,500 faculty members. As the state’s only academic health science center and largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $2.3 billion, with an annual economic impact of nearly $4 billion and annual research funding in excess of $250 million. MUSC operates a 700-bed medical center, which includes a nationally recognized children's hospital, the NCI-designated Hollings Cancer Center, a Level I trauma center, Institute of Psychiatry, more than 100 outreach locations across the state, and South Carolina’s only transplant center.